The German biotechnology firm BioNTech, once a beacon of innovation and a financial titan thanks to its pioneering mRNA COVID-19…
Read More
Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.
The pharmaceutical industry, emerging from a period characterized by uneven growth and significant challenges in research and development (R&D) productivity,…
Read More
Canada Becomes First G7 Nation to Approve Generic Semaglutide Following Novo Nordisk Patent Lapse, Paving Way for Enhanced Access and Affordability
In a landmark decision poised to significantly reshape the pharmaceutical landscape for diabetes and obesity management, Health Canada has granted…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…
Read More
BD, Wellstar connect pharmacy-to-bedside medication management with AI
BD, a global leader in medical technology, has officially announced a strategic partnership with Wellstar Health System, one of Georgia’s…
Read More
FDA Commissioner Marty Makary Resigns Amid Administration Pressure and Widespread Criticism
Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration following escalating rumors that President Donald Trump…
Read More
Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
The global oncology community converged at the American Association for Cancer Research (AACR) 2026 Annual Meeting in San Diego, a…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a burgeoning biotech startup, has announced the acquisition of global rights to a clinical-stage Parkinson’s disease cell therapy,…
Read More
Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery
In a remarkable breakthrough in ocular pharmacology, researchers in China have pioneered the development of novel eye drops derived from…
Read More
The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed ‘fastest growing company in history.’
The narrative of MEDVi, an AI-powered telehealth startup, recently unfolded with a stark duality: hailed by The New York Times…
Read MoreYOU MAY HAVE MISSED
